Showing results (51-60 of 5,675) with videos related to
Sort By:
Pageof 568
Journal of the Neurological Sciences|October 1, 1989
Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findingsG Orozco, R Estrada, T L Perry, et al.Annals of Neurology|October 1, 1985
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidusT L Perry, M G Norman, V W Yong, et al.Neurology|April 1, 1982
A double-blind clinical trial of isoniazid in Huntington diseaseT L Perry, J M Wright, S Hansen, et al.Journal of Neurochemistry|July 1, 1981
Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazidT L Perry, S J Kish, S Hansen, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|January 8, 1981
Studies of amino acid content and transport in glutathione-deficient erythrocytes from a patient with pyroglutamic acidemia (5-oxoprolinemia)S Marstein, T L PerryNeurochemical Research|April 1, 1987
Inability to produce a model of dialysis encephalopathy in the rat by aluminum administrationT L Perry, V W Yong, W J Godolphin, et al.Neuroscience Letters|September 30, 1985
Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseT L Perry, V W Yong, R M Clavier, et al.Neuroscience Letters|August 5, 1985
Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseT L Perry, V W Yong, K Jones, et al.Journal of the Neurological Sciences|February 1, 1986
Monoamine oxidase B, smoking, and Parkinson's diseaseV W Yong, T L PerryNeuroscience Letters|June 30, 1986
Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsT L Perry, V W YongPageof 568